Orciani M, Emanuelli M, Martino C, Pugnaloni A, Tranquilli A L, Di Primio R
Department of Molecular Pathology and Innovative Therapies, Histology Section, Marche Polytechnic University, Ancona, Italy.
Int J Immunopathol Pharmacol. 2008 Jul-Sep;21(3):595-602. doi: 10.1177/039463200802100312.
In recent years, the use of stem cells has generated increasing interest in regenerative medicine and cancer therapies. The most potent stem cells derive from the inner cell mass during embryonic development and their use yields serious ethical and methodological problems. Recently, a number of reports suggests that another suitable source of multipotent stem cells may be the amniotic fluid. Amniotic fluid mesenchymal stem cells (AFMSCs) are capable of extensive self-renewal, able to differentiate in specialized cells representative of all three germ layers, do not show ethical restriction, and display minimal risks of teratomas and a very low immunogenity. For all these reasons, amniotic fluid appears as a promising alternative source for stem cell therapy. Their recent discovery implies a lack of knowledge of their specific features as well as the existence of a protocol universally recognized as the most suitable for their isolation, growth and long-term conservation. In this study, we isolated stem cells from six amniotic fluids; these cells were cultured with three different culture mediums (Mesenchymal Stem Cell Medium (MSCGM), PC-1 and RPMI-1640), characterized by cytofluorimetric analysis, and then either frozen or induced to neuronal differentiation. Even if the immunophenotype seemed not to be influenced by culture medium (all six samples cultured in the above-mentioned mediums expressed surface antigens commonly found on stem cells), cells showed different abilities to differentiate into neuron-like cells and to re-start the culture after short/long-term storage. Cells isolated and cultured in MSCGM showed the highest proliferation rate, and formed neuron-like cells when sub-plated with neuronal differentiation medium. Cells from PC-1, on the contrary, displayed an increased ability to re-start culture after short/long term storage. Finally, cells from RPMI-1640, even if expressing stem cells markers, were not able to differentiate in neuron-like cells. Further studies are still needed in order to assess the effective role of culture medium for a successful isolation, growth, differentiation and storage of AFMSCs, but our data underline the importance of finding a universally accepted protocol for the use of these cells.
近年来,干细胞的应用在再生医学和癌症治疗领域引发了越来越多的关注。最具潜能的干细胞来源于胚胎发育过程中的内细胞团,其使用引发了严重的伦理和方法学问题。最近,一些报告表明羊膜液可能是另一种合适的多能干细胞来源。羊膜液间充质干细胞(AFMSCs)能够进行广泛的自我更新,能够分化为代表所有三个胚层的特化细胞,不存在伦理限制,并且畸胎瘤风险极小,免疫原性很低。基于所有这些原因,羊膜液似乎是干细胞治疗的一个有前景的替代来源。它们最近才被发现,这意味着人们对其特定特征缺乏了解,也缺乏一个被普遍认为最适合其分离、生长和长期保存的方案。在本研究中,我们从六份羊膜液中分离出干细胞;这些细胞用三种不同的培养基(间充质干细胞培养基(MSCGM)、PC - 1和RPMI - 1640)进行培养,通过细胞荧光分析进行表征,然后要么冷冻保存,要么诱导其向神经元分化。即使免疫表型似乎不受培养基影响(在上述培养基中培养的所有六个样本都表达干细胞上常见的表面抗原),但细胞在分化为神经元样细胞以及在短期/长期保存后重新开始培养方面表现出不同的能力。在MSCGM中分离和培养的细胞显示出最高的增殖率,当接种到神经元分化培养基中时可形成神经元样细胞。相反,来自PC - 1的细胞在短期/长期保存后重新开始培养的能力增强。最后,来自RPMI - 1640的细胞,即使表达干细胞标志物,也无法分化为神经元样细胞。为了评估培养基对AFMSCs成功分离、生长、分化和保存的有效作用,仍需要进一步研究,但我们的数据强调了找到一个普遍接受的使用这些细胞的方案的重要性。